Global Pre-Implantation Genetic Diagnosis (PGD) Market Growth (Status and Outlook) 2025-2031

September 2025 | 104 pages | ID: G73AD7A6E182EN
LP Information

Abstracts

According to this study, the global Pre-Implantation Genetic Diagnosis (PGD) market size will reach US$ 146 million by 2031.

Pre-Implantation Genetic Diagnosis (PGD) is the genetic profiling of embryos prior to implantation (as a form of embryo profiling), and sometimes even of oocytes prior to fertilization.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Pre-Implantation Genetic Diagnosis (PGD) Industry Forecast” looks at past sales and reviews total world Pre-Implantation Genetic Diagnosis (PGD) sales in 2024, providing a comprehensive analysis by region and market sector of projected Pre-Implantation Genetic Diagnosis (PGD) sales for 2025 through 2031. With Pre-Implantation Genetic Diagnosis (PGD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pre-Implantation Genetic Diagnosis (PGD) industry.

This Insight Report provides a comprehensive analysis of the global Pre-Implantation Genetic Diagnosis (PGD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pre-Implantation Genetic Diagnosis (PGD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pre-Implantation Genetic Diagnosis (PGD) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pre-Implantation Genetic Diagnosis (PGD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pre-Implantation Genetic Diagnosis (PGD).

This report presents a comprehensive overview, market shares, and growth opportunities of Pre-Implantation Genetic Diagnosis (PGD) market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Chromosomal Abnormalities
• X-linked Diseases
• Freeze Embryo Testing
• Aneuploidy Screening
• HLA
• Others

Segmentation by Application:

• Stem Cell Therapy
• IVF Prognosis
• Late-Onset Genetic Disorders
• Inherited Genetic Disease
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche
• Genea Limited
• Quest Diagnostics
• Illumina, Inc.
• Natera, Inc.
• Cooper Medical, Inc.
• LabCorp
• California Pacific Medical Center (CPMC)
• Thermo Fisher Scientific Inc.
• IGENOMIX
• Reproductive Genetic Innovations
• CombiMatrix

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (2020-2031)
  2.1.2 Pre-Implantation Genetic Diagnosis (PGD) Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Pre-Implantation Genetic Diagnosis (PGD) by Country/Region (2020, 2024 & 2031)
2.2 Pre-Implantation Genetic Diagnosis (PGD) Segment by Type
  2.2.1 Chromosomal Abnormalities
  2.2.2 X-linked Diseases
  2.2.3 Freeze Embryo Testing
  2.2.4 Aneuploidy Screening
  2.2.5 HLA
  2.2.6 Others
2.3 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
  2.3.1 Pre-Implantation Genetic Diagnosis (PGD) Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2020-2025)
2.4 Pre-Implantation Genetic Diagnosis (PGD) Segment by Application
  2.4.1 Stem Cell Therapy
  2.4.2 IVF Prognosis
  2.4.3 Late-Onset Genetic Disorders
  2.4.4 Inherited Genetic Disease
  2.4.5 Others
2.5 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
  2.5.1 Pre-Implantation Genetic Diagnosis (PGD) Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2020-2025)

3 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SIZE BY PLAYER

3.1 Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Player
  3.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Player (2020-2025)
  3.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Player (2020-2025)
3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) BY REGION

4.1 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025)
4.2 Global Pre-Implantation Genetic Diagnosis (PGD) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth (2020-2025)
4.4 APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth (2020-2025)
4.5 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth (2020-2025)
4.6 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2020-2025)
5.2 Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2020-2025)
5.3 Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025)
6.2 APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2020-2025)
6.3 APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2020-2025)
7.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2020-2025)
7.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) by Region (2020-2025)
8.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2020-2025)
8.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET FORECAST

10.1 Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Region (2026-2031)
  10.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Region (2026-2031)
  10.1.2 Americas Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.1.3 APAC Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.1.4 Europe Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.1.5 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Forecast
10.2 Americas Pre-Implantation Genetic Diagnosis (PGD) Forecast by Country (2026-2031)
  10.2.1 United States Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.2.2 Canada Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.2.3 Mexico Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.2.4 Brazil Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
10.3 APAC Pre-Implantation Genetic Diagnosis (PGD) Forecast by Region (2026-2031)
  10.3.1 China Pre-Implantation Genetic Diagnosis (PGD) Market Forecast
  10.3.2 Japan Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.3.3 Korea Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.3.4 Southeast Asia Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.3.5 India Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.3.6 Australia Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
10.4 Europe Pre-Implantation Genetic Diagnosis (PGD) Forecast by Country (2026-2031)
  10.4.1 Germany Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.4.2 France Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.4.3 UK Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.4.4 Italy Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.4.5 Russia Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
10.5 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Forecast by Region (2026-2031)
  10.5.1 Egypt Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.5.2 South Africa Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.5.3 Israel Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
  10.5.4 Turkey Market Pre-Implantation Genetic Diagnosis (PGD) Forecast
10.6 Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Type (2026-2031)
10.7 Global Pre-Implantation Genetic Diagnosis (PGD) Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Pre-Implantation Genetic Diagnosis (PGD) Forecast

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Pre-Implantation Genetic Diagnosis (PGD) Product Offered
  11.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Genea Limited
  11.2.1 Genea Limited Company Information
  11.2.2 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Offered
  11.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Genea Limited Main Business Overview
  11.2.5 Genea Limited Latest Developments
11.3 Quest Diagnostics
  11.3.1 Quest Diagnostics Company Information
  11.3.2 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Offered
  11.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Quest Diagnostics Main Business Overview
  11.3.5 Quest Diagnostics Latest Developments
11.4 Illumina, Inc.
  11.4.1 Illumina, Inc. Company Information
  11.4.2 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Offered
  11.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Illumina, Inc. Main Business Overview
  11.4.5 Illumina, Inc. Latest Developments
11.5 Natera, Inc.
  11.5.1 Natera, Inc. Company Information
  11.5.2 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Offered
  11.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Natera, Inc. Main Business Overview
  11.5.5 Natera, Inc. Latest Developments
11.6 Cooper Medical, Inc.
  11.6.1 Cooper Medical, Inc. Company Information
  11.6.2 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Offered
  11.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Cooper Medical, Inc. Main Business Overview
  11.6.5 Cooper Medical, Inc. Latest Developments
11.7 LabCorp
  11.7.1 LabCorp Company Information
  11.7.2 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Offered
  11.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 LabCorp Main Business Overview
  11.7.5 LabCorp Latest Developments
11.8 California Pacific Medical Center (CPMC)
  11.8.1 California Pacific Medical Center (CPMC) Company Information
  11.8.2 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Offered
  11.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 California Pacific Medical Center (CPMC) Main Business Overview
  11.8.5 California Pacific Medical Center (CPMC) Latest Developments
11.9 Thermo Fisher Scientific Inc.
  11.9.1 Thermo Fisher Scientific Inc. Company Information
  11.9.2 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Offered
  11.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Thermo Fisher Scientific Inc. Main Business Overview
  11.9.5 Thermo Fisher Scientific Inc. Latest Developments
11.10 IGENOMIX
  11.10.1 IGENOMIX Company Information
  11.10.2 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Offered
  11.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 IGENOMIX Main Business Overview
  11.10.5 IGENOMIX Latest Developments
11.11 Reproductive Genetic Innovations
  11.11.1 Reproductive Genetic Innovations Company Information
  11.11.2 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Offered
  11.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Reproductive Genetic Innovations Main Business Overview
  11.11.5 Reproductive Genetic Innovations Latest Developments
11.12 CombiMatrix
  11.12.1 CombiMatrix Company Information
  11.12.2 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Offered
  11.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 CombiMatrix Main Business Overview
  11.12.5 CombiMatrix Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pre-Implantation Genetic Diagnosis (PGD) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Pre-Implantation Genetic Diagnosis (PGD) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Chromosomal Abnormalities
Table 4. Major Players of X-linked Diseases
Table 5. Major Players of Freeze Embryo Testing
Table 6. Major Players of Aneuploidy Screening
Table 7. Major Players of HLA
Table 8. Major Players of Others
Table 9. Pre-Implantation Genetic Diagnosis (PGD) Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2020-2025) & ($ millions)
Table 11. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2020-2025)
Table 12. Pre-Implantation Genetic Diagnosis (PGD) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2020-2025) & ($ millions)
Table 14. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2020-2025)
Table 15. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Player (2020-2025)
Table 17. Pre-Implantation Genetic Diagnosis (PGD) Key Players Head office and Products Offered
Table 18. Pre-Implantation Genetic Diagnosis (PGD) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Region (2020-2025)
Table 23. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Country (2020-2025)
Table 27. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2020-2025)
Table 29. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2020-2025)
Table 31. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Region (2020-2025)
Table 33. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Country (2020-2025)
Table 37. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Pre-Implantation Genetic Diagnosis (PGD)
Table 43. Key Market Challenges & Risks of Pre-Implantation Genetic Diagnosis (PGD)
Table 44. Key Industry Trends of Pre-Implantation Genetic Diagnosis (PGD)
Table 45. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Roche Details, Company Type, Pre-Implantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 50. Roche Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 51. Roche Pre-Implantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Roche Main Business
Table 53. Roche Latest Developments
Table 54. Genea Limited Details, Company Type, Pre-Implantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 55. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 56. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Genea Limited Main Business
Table 58. Genea Limited Latest Developments
Table 59. Quest Diagnostics Details, Company Type, Pre-Implantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 60. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 61. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Quest Diagnostics Main Business
Table 63. Quest Diagnostics Latest Developments
Table 64. Illumina, Inc. Details, Company Type, Pre-Implantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 65. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 66. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Illumina, Inc. Main Business
Table 68. Illumina, Inc. Latest Developments
Table 69. Natera, Inc. Details, Company Type, Pre-Implantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 70. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 71. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Natera, Inc. Main Business
Table 73. Natera, Inc. Latest Developments
Table 74. Cooper Medical, Inc. Details, Company Type, Pre-Implantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 75. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 76. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Cooper Medical, Inc. Main Business
Table 78. Cooper Medical, Inc. Latest Developments
Table 79. LabCorp Details, Company Type, Pre-Implantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 80. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 81. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. LabCorp Main Business
Table 83. LabCorp Latest Developments
Table 84. California Pacific Medical Center (CPMC) Details, Company Type, Pre-Implantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 85. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 86. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. California Pacific Medical Center (CPMC) Main Business
Table 88. California Pacific Medical Center (CPMC) Latest Developments
Table 89. Thermo Fisher Scientific Inc. Details, Company Type, Pre-Implantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 90. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 91. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Thermo Fisher Scientific Inc. Main Business
Table 93. Thermo Fisher Scientific Inc. Latest Developments
Table 94. IGENOMIX Details, Company Type, Pre-Implantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 95. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 96. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. IGENOMIX Main Business
Table 98. IGENOMIX Latest Developments
Table 99. Reproductive Genetic Innovations Details, Company Type, Pre-Implantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 100. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 101. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. Reproductive Genetic Innovations Main Business
Table 103. Reproductive Genetic Innovations Latest Developments
Table 104. CombiMatrix Details, Company Type, Pre-Implantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 105. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Offered
Table 106. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. CombiMatrix Main Business
Table 108. CombiMatrix Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Pre-Implantation Genetic Diagnosis (PGD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Pre-Implantation Genetic Diagnosis (PGD) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country/Region (2024)
Figure 8. Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2024
Figure 10. Pre-Implantation Genetic Diagnosis (PGD) in Stem Cell Therapy
Figure 11. Global Pre-Implantation Genetic Diagnosis (PGD) Market: Stem Cell Therapy (2020-2025) & ($ millions)
Figure 12. Pre-Implantation Genetic Diagnosis (PGD) in IVF Prognosis
Figure 13. Global Pre-Implantation Genetic Diagnosis (PGD) Market: IVF Prognosis (2020-2025) & ($ millions)
Figure 14. Pre-Implantation Genetic Diagnosis (PGD) in Late-Onset Genetic Disorders
Figure 15. Global Pre-Implantation Genetic Diagnosis (PGD) Market: Late-Onset Genetic Disorders (2020-2025) & ($ millions)
Figure 16. Pre-Implantation Genetic Diagnosis (PGD) in Inherited Genetic Disease
Figure 17. Global Pre-Implantation Genetic Diagnosis (PGD) Market: Inherited Genetic Disease (2020-2025) & ($ millions)
Figure 18. Pre-Implantation Genetic Diagnosis (PGD) in Others
Figure 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market: Others (2020-2025) & ($ millions)
Figure 20. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2024
Figure 21. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Player in 2024
Figure 22. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Region (2020-2025)
Figure 23. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size 2020-2025 ($ millions)
Figure 24. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size 2020-2025 ($ millions)
Figure 25. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size 2020-2025 ($ millions)
Figure 27. Americas Pre-Implantation Genetic Diagnosis (PGD) Value Market Share by Country in 2024
Figure 28. United States Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Region in 2024
Figure 33. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2020-2025)
Figure 34. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2020-2025)
Figure 35. China Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 39. India Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Country in 2024
Figure 42. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2020-2025)
Figure 43. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2020-2025)
Figure 44. Germany Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 45. France Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 58. APAC Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 59. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 61. United States Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 62. Canada Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 63. Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 64. Brazil Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 65. China Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 66. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 67. Korea Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 69. India Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 70. Australia Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 71. Germany Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 72. France Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 73. UK Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 74. Italy Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 75. Russia Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 76. Egypt Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 77. South Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 78. Israel Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 79. Turkey Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)
Figure 80. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Pre-Implantation Genetic Diagnosis (PGD) Market Size 2026-2031 ($ millions)